|
1
|
Szakács G, Paterson JK, Ludwig JA,
Booth-Genthe C and Gottesman MM: Targeting multidrug resistance in
cancer. Nat Rev Drug Discov. 5:219–234. 2006.
|
|
2
|
Liscovitch M and Lavie Y: Cancer multidrug
resistance: a review of recent drug discovery research. IDrugs.
5:349–355. 2002.PubMed/NCBI
|
|
3
|
Kitagawa I, Yoshikawa M, Yoshihara M,
Hayashi T and Taniyama T: Chemical studies of crude drugs (1).
Constituents of Ginseng radix rubra. Yakugaku Zasshi. 103:612–622.
1983.(In Japanese).
|
|
4
|
Kim SW, Kwon HY, Chi DW, et al: Reversal
of P-glycoprotein-mediated multidrug resistance by ginsenoside
Rg(3). Biochem Pharmacol. 65:75–82. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Molnár J, Szabó D, Pusztai R, et al:
Membrane associated antitumor effects of crocine-, ginsenoside- and
cannabinoid derivates. Anticancer Res. 20:861–867. 2000.PubMed/NCBI
|
|
6
|
Tachikawa E, Kudo K, Nunokawa M, Kashimoto
T, Takahashi E and Kitagawa S: Characterization of ginseng saponin
ginsenoside-Rg(3) inhibition of catecholamine secretion in bovine
adrenal chromaffin cells. Biochem Pharmacol. 62:943–951. 2001.
View Article : Google Scholar
|
|
7
|
Jin J, Shahi S, Kang HK, van Veen HW and
Fan TP: Metabolites of ginsenosides as novel BCRP inhibitors.
Biochem Biophys Res Commun. 345:1308–1314. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Marquardt D, McCrone S and Center MS:
Mechanisms of multidrug resistance in HL60 cells: detection of
resistance-associated proteins with antibodies against synthetic
peptides that correspond to the deduced sequence of P-glycoprotein.
Cancer Res. 50:1426–1430. 1990.
|
|
9
|
Steel GG and Peckham MJ: Exploitable
mechanisms in combined radiotherapy-chemotherapy: the concept of
additivity. Int J Radiat Oncol Biol Phys. 5:85–91. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kano Y, Ohnuma T, Okano T and Holland JF:
Effects of vincristine in combination with methotrexate and other
antitumor agents in human acute lymphoblastic leukemia cells in
culture. Cancer Res. 48:351–356. 1988.PubMed/NCBI
|
|
11
|
Kano Y, Suzuki K, Akutsu M, et al: Effects
of CPT-11 in combination with other anti-cancer agents in culture.
Int J Cancer. 50:604–610. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Steel GG: Terminology in the description
of drug-radiation interactions. Int J Radiat Oncol Biol Phys.
5:1145–1150. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ford JM and Hait WN: Pharmacologic
circumvention of multidrug resistance. Cytotechnology. 12:171–212.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tsuruo T, Iida H, Tsukagoshi S and Sakurai
Y: Overcoming of vincristine resistance in P388 leukemia in vivo
and in vitro through enhanced cytotoxicity of vincristine and
vinblastine by verapamil. Cancer Res. 41:1967–1972. 1981.PubMed/NCBI
|
|
15
|
Belpomme D, Gauthier S, Pujade-Lauraine E,
et al: Verapamil increases the survival of patients with
anthracycline-resistant metastatic breast carcinoma. Annal Oncol.
11:1471–1476. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hu XF, Martin TJ, Bell DR, de Luise M and
Zalcberg JR: Combined use of cyclosporin A and verapamil in
modulating multidrug resistance in human leukemia cell lines.
Cancer Res. 50:2953–2957. 1990.
|
|
17
|
Ford JM, Bruggemann EP, Pastan I,
Gottesman MM and Hait WN: Cellular and biochemical characterization
of thioxanthenes for reversal of multidrug resistance in human and
murine cell lines. Cancer Res. 50:1748–1756. 1990.PubMed/NCBI
|
|
18
|
Van de Vrie W, Jonker AM, Marquet RL and
Eggermont AM: The chemosensitizer cyclosporin A enhances the toxic
side-effects of doxorubicin in the rat. J Cancer Res Clin Oncol.
120:533–538. 1994.PubMed/NCBI
|
|
19
|
Lü JM, Yao Q and Chen C: Ginseng
compounds: an update on their molecular mechanisms and medical
applications. Curr Vasc Pharmacol. 7:293–302. 2009.PubMed/NCBI
|
|
20
|
Park JD, Kim DS, Kwan HY, Son SK, Lee YH,
Beak NI, et al: Effects of ginseng saponin on modulation of
multidrug resistance. Arch Pharm Res. 19:213–218. 1996. View Article : Google Scholar
|
|
21
|
Jia WW, Bu X, Philips D, et al: Rh2, a
compound extracted from ginseng, hypersensitizes
multidrug-resistant tumor cells to chemotherapy. Can J Physiol
Pharmacol. 82:431–437. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Helms S: Cancer prevention and
therapeutics: Panax ginseng. Altern Med Rev. 9:259–274.
2004.
|
|
23
|
Yuan HD, Quan HY, Zhang Y, Kim SH and
Chung SH: 20(S)-Ginsenoside Rg3-induced apoptosis in HT-29 colon
cancer cells is associated with AMPK signaling pathway. Mol Med
Rep. 3:825–831. 2010.PubMed/NCBI
|
|
24
|
Jian J, Hu ZF and Huang Y: Effect of
ginsenoside Rg3 on Pim-3 and Bad proteins in human pancreatic
cancer cell line PANC-1. Ai Zheng. 28:461–465. 2009.(In
Chinese).
|
|
25
|
Wang BS, Zhang LS, Song DM, Zhang JH and
Liu YM: Effect of gensenoside Rg3 on apoptosis of Hep-2 and
expression of HIF-1alpha in human laryngeal cancer cell line under
anoxic conditions. Zhong Yao Cai. 32:102–106. 2009.(In
Chinese).
|
